Leukine (Sargramostim) for Parkinson's Disease
Latest Information Update: 09 Oct 2023
At a glance
- Drugs Sargramostim (Primary)
- Indications Parkinson's disease
- Focus Adverse reactions
- 17 Sep 2014 Planned primary completion date changed from 1 Jan 2015 to 1 Sep 2015 as reported by ClinicalTrials.gov record.
- 17 Sep 2014 Planned End Date changed from 1 Jan 2016 to 1 Sep 2016 as reported by ClinicalTrials.gov record.
- 23 Sep 2013 Planned End Date changed from 1 Jun 2015 to 1 Jan 2016 as reported by ClinicalTrials.gov record.